Addiction & agency
Must addiction be disease or vice?
Open access · cc by · source: Europe PMC
Heather argues the BDMA’s political claim — that only a brain-disease story can fight stigma — is false, and that addiction is neither brain disease nor moral failing.
Study at a glance
- Design
- Other — Philosophical/public-discourse critique that addiction is neither brain disease nor moral failing
- N
- Conceptual and stigma-literature analysis; not a primary sample
- Population
- BDMA political claims about stigma and public understanding of addiction
- Outcome
- Addiction as a disorder of choice requiring a new governing image beyond disease/blame
Structured fields used in claim comparison tables when every cited study has a complete layer.
Key findings
The BDMA’s main practical effect, he fears, is more medicalisation and pharma collaboration rather than understanding what addiction is about. He calls BDMA inhumane and unintelligent in its eliminative reductionism.
Methodology
Using Lewis as a springboard, Heather attacks Leshner-style claims that rejecting BDMA equals calling addicts immoral. He reviews public understanding, stigma evidence, and presents addiction as a disorder of choice, calling for a new governing image in public discourse.
Limitations
This is a socio-political essay, not a new stigma experiment. He does not fully specify the public messaging for a disorder-of-choice model.
How this study connects
Role on claims
Each row is a claim on a concept or method page where this paper supports, challenges, or qualifies the statement. Roles are hand-checked — not a model guess.
Several papers reject the slogan that only a chronic brain-disease story can fight stigma or explain compulsion.
Evidence for the claim as stated.
Authors split on whether there is a temporary disease-like or duress-like stage: Snoek models one that recovery can pass through, while Heather and Lewis reject chronic-disease framing more flatly.
Evidence for the claim as stated.
The method has been used to test the political claims of the brain disease model of addiction (BDMA) against what is known about stigma and public understanding. Heather concludes that the claim that only a brain-disease story can fight stigma is false and that addiction is neither brain disease nor moral failing; Snoek separates the model's technical mechanisms from its normative translation into 'chronic disease' and argues that the label can undermine belief in self-efficacy.
Evidence for the claim as stated.
How much of the brain disease model to keep. Heather rejects it wholesale, calling its eliminative reductionism inhumane and unintelligent and fearing more medicalisation and pharma collaboration; Snoek, following Lewis, accepts most of the mechanisms and keeps a temporary, duress-like disease stage that recovery can pass through. Both engage the same stigma and self-efficacy considerations but land in different places.
Evidence for the claim as stated.
Open questions
Tensions this paper is part of
From concept pages' “where studies disagree.” Disagreement means the same question; scope means different assays, populations, or outcomes.
Authors split on whether there is a temporary disease-like or duress-like stage: Snoek models one that recovery can pass through, while Heather and Lewis reject chronic-disease framing more flatly.
- Supports · Is there a disease-like stage in addiction?
- Supports · Is addiction a brain disease or development?
How much of the brain disease model to keep. Heather rejects it wholesale, calling its eliminative reductionism inhumane and unintelligent and fearing more medicalisation and pharma collaboration; Snoek, following Lewis, accepts most of the mechanisms and keeps a temporary, duress-like disease stage that recovery can pass through. Both engage the same stigma and self-efficacy considerations but land in different places.
- Supports · Is there a disease-like stage in addiction?
Related papers in this topic
Same topic cluster — not a recommendation engine.